CN Patent

CN114209654A — 布比卡因多囊脂质体的制备

Assigned to Pacira Pharmaceuticals Inc · Expires 2022-03-22 · 4y expired

What this patent protects

本申请的实施方案涉及使用独立操作的双切向流过滤模块制备布比卡因多囊脂质体(MVL)的商业制造方法。

USPTO Abstract

本申请的实施方案涉及使用独立操作的双切向流过滤模块制备布比卡因多囊脂质体(MVL)的商业制造方法。

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: CN114209654A
Jurisdiction: CN
Classification: —
Expires: 2022-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Pacira Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.